Simon Hufton,
Section Head Molecular Immunology,
National Institute for Biological Standard and Control (NIBSC)
Dr Simon E. Hufton has over 20-years’ experience in the therapeutic monoclonal antibody field gained as Director Research for Dyax Corp and Wyeth. He joined NIBSC in 2009 and is currently Head of Molecular Immunology within the Biotherapeutics Division. He has authored over 40 publications and patents covering various aspects of monoclonal antibody research and development including biomolecular display technologies and single domain antibodies. He is a biochemist by training and received his undergraduate degree from The University of Manchester, UK and his PhD at Nottingham University, UK. His research interests include immunotherapy and antibody engineering related to efficacy, quality and safety of biological medicines.
|
|
|
Add to Calendar ▼2017-03-06 09:30:002017-03-06 10:30:00Europe/LondonCross-Neutralising Single Domain Antibodies to Influenza – Preparing for the Next PandemicSELECTBIOenquiries@selectbiosciences.com
.gif){kind=logo}
